Lisinopril-associated bullous pemphigoid in an elderly woman: a case report of a rare adverse drug reaction

British Journal of Clinical Pharmacology
Rami A BalloutJoe Khattar

Abstract

An 87-year-old woman with a long-standing history of hypertension, hypothyroidism and diabetes presented to us with scaly and pruritic vesicles of an erythematous base and crusted surface of 2-month duration. They first appeared on her abdomen and gradually spread to her lower back, thighs, before spreading to her upper and lower limbs. Her lesions were non-painful, aggravated by sun exposure only, and sparing mucous membranes. Nikolsky sign was positive with no discernible fluid-filled bullae. History was remarkable only for a doubling of her Lisinopril dosage 2 months prior to the appearance of her lesions, with no other potential environmental and/or drug triggers recognizable on history taking. In light of the appearance of her lesions after her Lisinopril dose escalation, in the absence of any other discernible triggers, an adverse drug reaction (ADR) was entertained, yielding a corresponding Naranjo ADR probability score of 7. Particularly, drug-induced pemphigus foliaceus was initially suspected given her clinical presentation and the morphology and distribution of her lesions. However, her skin biopsy altered our diagnosis to drug-induced bullous pemphigoid (BP) instead, making this the second case reported to date on L...Continue Reading

References

Jan 1, 1992·International Journal of Dermatology·V RuoccoV Guerrera
Jan 1, 1989·DICP : the Annals of Pharmacotherapy·L MalletJ Thomas
Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Nov 1, 1993·Journal of the American Academy of Dermatology·E P SmithJ J Zone
Oct 29, 2002·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Ozcan CakmakLevent Ozluoglu
Feb 3, 2004·The Journal of Dermatological Treatment·C R S Patterson, M G Davies
Aug 3, 2005·Biopharmaceutics & Drug Disposition·J J I TamimiRuwayda Dham
Sep 13, 2006·The British Journal of Dermatology·A Kalińska-BieniasC Kowalewski
Nov 21, 2007·Clinical and Experimental Dermatology·R SaracenoS Chimenti
Feb 10, 2009·International Journal of Dermatology·Aikaterini PatsatsiDimitrios Sotiriadis
May 25, 2011·Dermatologic Clinics·Kirk A JamesLuis A Diaz
Jun 18, 2011·Clinics in Dermatology·Sarah Brenner, Ilan Goldberg
Jun 29, 2013·Clinics in Dermatology·Ada Lo SchiavoRonni Wolf
Jan 11, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·P G StavropoulosC Antoniou
Mar 2, 2017·American Journal of Clinical Dermatology·Philippe Bernard, Frank Antonicelli
Aug 3, 2017·Einstein·Louise de Almeida Ferreira FonsecaClóvis Antônio Lopes Pinto
Oct 22, 2017·British Journal of Pharmacology·Stephen Ph AlexanderUNKNOWN CGTP Collaborators
Oct 22, 2017·British Journal of Pharmacology·Stephen Ph AlexanderUNKNOWN CGTP Collaborators

❮ Previous
Next ❯

Citations

Aug 30, 2019·Dermatologic Therapy·Tianjing WangGuangpu Luo
Aug 19, 2020·British Journal of Haematology·Theodora FoukaneliUNKNOWN BCSH Committee
Jul 3, 2021·Case Reports in Dermatological Medicine·Natalie OlsonAngela Delano
Oct 5, 2021·Journal of the European Academy of Dermatology and Venereology : JEADV·V SchmidtM Möhrenschlager

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

European Journal of Dermatology : EJD
Masumi TsujiwakiHiroshi Shimizu
Indian Journal of Dermatology, Venereology and Leprology
V MendirattaR V Korann
Korean journal of family medicine
Ki Dong KoIn Cheol Hwang
© 2022 Meta ULC. All rights reserved